More than 7 million Americans have Alzheimer's, and a recent report found that over 90% of Americans would want to use a simple blood-based biomarker test to detect Alzheimer's if it was available to them.
Capitol Hill has heard those calls, introducing bipartisan legislation called the ASAP Act, which would cover the blood-based medical tests in the Medicare program and improve early detection of Alzheimer's disease.
Please join The Hill & the Alliance for Aging Research for "Getting a Diagnosis ASAP: Progress in Early Alzheimer's Detection" program on March 26th as we convene lawmakers, Alzheimer's advocates, and health care experts to make sense of the hurdles currently in place to receive an early Alzheimer's diagnosis and forge a path forward for patients. |
|
|
SPEAKERS: Rep. Vern Buchanan (R-Fla.), Co-Sponsor, ASAP Act & Vice-Chair, Ways & Means Committee Rep. Paul Tonko (D-N.Y.), Co-Sponsor, ASAP Act & Member, Energy & Commerce Committee Joe Grogan, Nonresident Senior Scholar, USC Schaeffer Institute & Former Director, Domestic Policy Council & Assistant to President Trump John Dwyer, President, Global Alzheimer's Platform Foundation Carole Roan Gresenz, Dean, McCourt School of Public Policy, Georgetown University & Former Senior Advisor for Strategic Health Initiatives, President Biden's Administration Dr. Cara Leahy, Director, Cognitive Disorders, Memorial Healthcare & Doctor of Neurology, Memorial Healthcare Institute Jay Reinstein, Alzheimer's Advocate & Patient Sue Peschin, President & CEO, Alliance for Aging Research
|
Event Details
Date: Thursday, Mar. 26
Program begins: 8:30 a.m ET
Program concludes: 10:00 a.m ET
Location: Washington, D.C., and streaming nationwide
|
|
|
|
If you believe this has been sent to you in error, please safely unsubscribe.
No comments:
Post a Comment